Alnylam Pharmaceuticals Inc

NASDAQ: ALNY
$277.43
+$5.21 (+1.9%)
Closing Price on November 8, 2024

ALNY Articles

Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy and Yum Brands.
The top analyst upgrades, downgrades and initiations seen from Monday include Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald's and Snap.
The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.
It seems that analysts are taking the forefront and making calls on where the biopharma industry is going ahead of action by the Trump administration.
A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
Here are some of the companies that reported notable insider buying last week, including Cheniere Energy and Lands' End.
Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good sense now and have outstanding upside potential.
The late-summer doldrums are over and the markets are on the move again as we are now in the fourth quarter. But a few companies held the market back from pushing even higher.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Advanced Micro Devices, Cliffs Natural Resources, Gap, KLA-Tencor, Regions Financial, Tyson Foods and Wal-Mart.
October 6, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by a slight margin...
Alnylam Pharmaceuticals saw its shares crash on Thursday after the company announced that it will be discontinuing one of its late-stage trials.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include American Express, Encana, Petrobras, Raytheon, Tesla and Walgreens.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, BlackBerry, eBay, Fitbit, Lululemon Athletica and Nike.